140 related articles for article (PubMed ID: 20175781)
1. Major vault protein forms complexes with hypoxia-inducible factor (HIF)-1alpha and reduces HIF-1alpha level in ACHN human renal adenocarcinoma cells.
Iwashita K; Ikeda R; Takeda Y; Sumizawa T; Furukawa T; Yamaguchi T; Akiyama S; Yamada K
Cancer Sci; 2010 Apr; 101(4):920-6. PubMed ID: 20175781
[TBL] [Abstract][Full Text] [Related]
2. MVP and vaults: a role in the radiation response.
Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
4. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
Zheng CL; Sumizawa T; Che XF; Tsuyama S; Furukawa T; Haraguchi M; Gao H; Gotanda T; Jueng HC; Murata F; Akiyama S
Biochem Biophys Res Commun; 2005 Jan; 326(1):100-7. PubMed ID: 15567158
[TBL] [Abstract][Full Text] [Related]
5. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
6. Cellular functions of vaults and their involvement in multidrug resistance.
Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
[TBL] [Abstract][Full Text] [Related]
7. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha.
Luo W; Zhong J; Chang R; Hu H; Pandey A; Semenza GL
J Biol Chem; 2010 Feb; 285(6):3651-3663. PubMed ID: 19940151
[TBL] [Abstract][Full Text] [Related]
8. FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.
Ju UI; Park JW; Park HS; Kim SJ; Chun YS
Biochem Biophys Res Commun; 2015 Sep; 464(4):1008-1015. PubMed ID: 26187670
[TBL] [Abstract][Full Text] [Related]
9. RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells.
Lee SH; Bae SC; Kim KW; Lee YM
Oncogene; 2014 Mar; 33(11):1458-67. PubMed ID: 23542169
[TBL] [Abstract][Full Text] [Related]
10. Identification of an alternative mechanism of degradation of the hypoxia-inducible factor-1alpha.
André H; Pereira TS
J Biol Chem; 2008 Oct; 283(43):29375-84. PubMed ID: 18694926
[TBL] [Abstract][Full Text] [Related]
11. STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination.
Jung JE; Kim HS; Lee CS; Shin YJ; Kim YN; Kang GH; Kim TY; Juhnn YS; Kim SJ; Park JW; Ye SK; Chung MH
Exp Mol Med; 2008 Oct; 40(5):479-85. PubMed ID: 18985005
[TBL] [Abstract][Full Text] [Related]
12. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
13. OTUB1 augments hypoxia signaling via its non-canonical ubiquitination inhibition of HIF-1α during hypoxia adaptation.
Liu X; Deng H; Tang J; Wang Z; Zhu C; Cai X; Rong F; Chen X; Sun X; Jia S; Ouyang G; Li W; Xiao W
Cell Death Dis; 2022 Jun; 13(6):560. PubMed ID: 35732631
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells.
Lin HC; Su SL; Lu CY; Lin AH; Lin WC; Liu CS; Yang YC; Wang HM; Lii CK; Chen HW
Environ Toxicol; 2017 Mar; 32(3):918-930. PubMed ID: 27297870
[TBL] [Abstract][Full Text] [Related]
15. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy.
Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G
PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma.
Gao YH; Li CX; Shen SM; Li H; Chen GQ; Wei Q; Wang LS
Biochem Biophys Res Commun; 2013 May; 435(1):46-51. PubMed ID: 23611775
[TBL] [Abstract][Full Text] [Related]
18. Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice.
Devine RD; Bicer S; Reiser PJ; Wold LE
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1154-H1162. PubMed ID: 28341633
[TBL] [Abstract][Full Text] [Related]
19. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
Seo K; Seo S; Ki SH; Shin SM
Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
